Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126391551 | 12639155 | 1 | I | 20160804 | 20160810 | 20160810 | EXP | CA-ROCHE-1809565 | ROCHE | 0.00 | A | F | Y | 0.00000 | 20160810 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126391551 | 12639155 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | U | UNKNOWN | 125276 | |||||||||
| 126391551 | 12639155 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | U | 0 | ||||||||||
| 126391551 | 12639155 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 0 | |||||||||||
| 126391551 | 12639155 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 0 | 20 | MG | QD | ||||||||
| 126391551 | 12639155 | 5 | SS | ORENCIA | ABATACEPT | 1 | Unknown | U | 0 | ||||||||||
| 126391551 | 12639155 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 0 | 1 | G | QD | ||||||||
| 126391551 | 12639155 | 7 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 0 | 15 | MG | /wk | ||||||||
| 126391551 | 12639155 | 8 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | PER DAY | 0 | 400 | MG | ||||||||
| 126391551 | 12639155 | 9 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126391551 | 12639155 | 1 | Product used for unknown indication |
| 126391551 | 12639155 | 2 | Product used for unknown indication |
| 126391551 | 12639155 | 3 | Rheumatoid arthritis |
| 126391551 | 12639155 | 4 | Product used for unknown indication |
| 126391551 | 12639155 | 5 | Product used for unknown indication |
| 126391551 | 12639155 | 6 | Rheumatoid arthritis |
| 126391551 | 12639155 | 7 | Rheumatoid arthritis |
| 126391551 | 12639155 | 8 | Product used for unknown indication |
| 126391551 | 12639155 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126391551 | 12639155 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126391551 | 12639155 | Abdominal discomfort | |
| 126391551 | 12639155 | Drug ineffective | |
| 126391551 | 12639155 | Joint swelling | |
| 126391551 | 12639155 | Leukopenia | |
| 126391551 | 12639155 | Rash | |
| 126391551 | 12639155 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126391551 | 12639155 | 2 | 2014 | 0 | ||
| 126391551 | 12639155 | 3 | 2013 | 0 | ||
| 126391551 | 12639155 | 4 | 201210 | 201312 | 0 | |
| 126391551 | 12639155 | 6 | 200404 | 2005 | 0 | |
| 126391551 | 12639155 | 7 | 201204 | 201208 | 0 | |
| 126391551 | 12639155 | 8 | 200206 | 200401 | 0 | |
| 126391551 | 12639155 | 9 | 20150901 | 0 |